Stock listing

AVBP Stock Price, News, Filings & Events — Arrivent Biopharma, Inc.

Selected listing: AVBP · BOATS · USD · US

This page tracks Arrivent Biopharma, Inc.'s AVBP:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AVBP:BOATS. AVBP:BOATS is the stock-level entry point for investors researching Arrivent Biopharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Arrivent Biopharma, Inc. is a public company traded under the ticker AVBP in the American market. The company has a market capitalization of approximately $1.55 billion. Arrivent focuses on developing innovative biopharmaceutical solutions to address unmet medical needs.

AVBP:BOATSUSDUSUpdated September 11, 2026
Arrivent Biopharma, Inc. logo
Ticker
AVBP:BOATS
Asset type
Stock
Market cap
$1.43B
Sector
Health Technology
Industry
Pharmaceuticals: Other
Exchange
BOATS
Currency
USD

Arrivent Biopharma, Inc. AVBP:BOATS stock context

This page tracks Arrivent Biopharma, Inc.'s AVBP:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following AVBP:BOATS. AVBP:BOATS is the stock-level entry point for investors researching Arrivent Biopharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Arrivent Biopharma, Inc. is a public company traded under the ticker AVBP in the American market. The company has a market capitalization of approximately $1.55 billion. Arrivent focuses on developing innovative biopharmaceutical solutions to address unmet medical needs.

Latest news from Arrivent Biopharma, Inc.

All Arrivent Biopharma, Inc. news →

Research Arrivent Biopharma, Inc.

Alternate listings